GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Market Cap

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Market Cap : $17.52 Mil (As of May. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CERo Therapeutics Holdings's share price for the quarter that ended in Dec. 2022 was $0. CERo Therapeutics Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2022 was 10.29 Mil. Therefore, CERo Therapeutics Holdings's market cap for the quarter that ended in Dec. 2022 was $0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CERo Therapeutics Holdings's Enterprise Value for Today is $14.99 Mil.

CERo Therapeutics Holdings Market Cap Historical Data

The historical data trend for CERo Therapeutics Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Market Cap Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Market Cap
- -

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Market Cap - -

Competitive Comparison of CERo Therapeutics Holdings's Market Cap

For the Biotechnology subindustry, CERo Therapeutics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CERo Therapeutics Holdings's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CERo Therapeutics Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where CERo Therapeutics Holdings's Market Cap falls into.


CERo Therapeutics Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CERo Therapeutics Holdings's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=$0*10.293
=$0.00

CERo Therapeutics Holdings's Market Cap for the quarter that ended in Dec. 2022 is calculated as

Market Cap (Q: Dec. 2022 )=Share Price (Q: Dec. 2022 )*Shares Outstanding (EOP) (Q: Dec. 2022 )
=$0*10.293
=$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CERo Therapeutics Holdings  (NAS:CERO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

CERo Therapeutics Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Market Cap
Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
Website
https://www.cero.bio
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024